Please use this identifier to cite or link to this item: http://repository.kln.ac.lk/handle/123456789/1870
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPremawardhena, A.en_US
dc.contributor.authorArambepola, M.en_US
dc.contributor.authorKatugaha, N.en_US
dc.contributor.authorWeatherall, D. J.en_US
dc.date.accessioned2014-10-29T09:27:02Z
dc.date.available2014-10-29T09:27:02Z
dc.date.issued2008en_US
dc.identifier.citationBritish Journal of Haematology. 2008; 141(3): 407-10en_US
dc.identifier.issn0007-1048 (Print)en_US
dc.identifier.issn1365-2141 (Electronic)en_US
dc.identifier.urihttp://repository.kln.ac.lk/handle/123456789/1870
dc.descriptionIndexed in MEDLINE
dc.description.abstractAlthough the beta thalassaemia trait affects millions of people worldwide, there have been no controlled studies to determine whether it is associated with any clinical disability or abnormal physical signs. To address this question, 402 individuals were studied: 217 with beta thalassaemia trait, of whom 154 were aware of the diagnosis and 63 were unaware until after the completion of the study; 89 normal controls; and 96 controls with mild hypochromic anaemia. There was a significant increase in symptoms ascribable to anaemia and episodes of pyrexia in those with the beta thalassaemia trait that were not influenced by prior knowledge that they had this condition. There was no difference in physical findings, notably splenomegaly, between those with beta thalassaemia trait and either control groupen_US
dc.publisherWiley-Blackwellen_US
dc.subjectThalassemiaen_US
dc.subjectbeta-Thalassemiaen_US
dc.subjectbeta-Thalassemia-complicationsen_US
dc.subjectbeta-Thalassemia-geneticsen_US
dc.titleIs the beta thalassaemia trait of clinical importance?en_US
dc.typeArticleen_US
dc.identifier.departmentMedicineen_US
Appears in Collections:Journal/Magazine Articles

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.